ServicenavigationHauptnavigationTrailKarteikarten

Forschungsstelle
INNOSUISSE
Projektnummer
43016.1 IP-LS
Projekttitel
Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.
Projekttitel Englisch
Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.

Texte zu diesem Projekt
 DeutschFranzösischItalienischEnglisch
Schlüsselwörter
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen

Erfasste Texte


KategorieText
Schlüsselwörter
(Englisch)
Life sciences, Pharmaceuticals
Abstract
(Englisch)
Cellestia Biotech is a clinical stage company based in Basel, Switzerland. The company is developing first-in-class innovative anti-cancer therapies by targeting undruggable transcription factors (TFs). The aim of the study is to expand pipeline by designing and developing novel anti-cancer agents.